Equity Overview
Price & Market Data
Price: $10.19
Daily Change: -$4.08 / 40.04%
Daily Range: $7.75 - $14.27
Market Cap: $2,736,026,880
Daily Volume: 1,450
Performance Metrics
1 Week: -25.16%
1 Month: -25.16%
3 Months: -33.12%
6 Months: 6.80%
1 Year: -82.67%
YTD: -25.16%
Details
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.